COVID-19 detection kit CFP01

SARS-COV-2nasopharyngealsputum

The CHAINFOR SARS-CoV-2 Detection RT-qPCR kit is intended for in vitro diagnosis of SARS-CoV-2 nucleic acids from nasopharyngeal aspirate/lavage, bronchoalveolar lavage, nasopharyngeal swab, and oropharyngeal swab qualitatively. Advantage – Simple and rapid detection by qPCR – No cross-reaction with common human respiatory CoV or MERS Details The CHAINFOR SARS-CoV-2 Detection RT-qPCR Kit is intended for in vitro qualitative diagnosis of SARS-CoV-2 nucleic acids from nasopharyngeal aspirate/lavage, bronchoalveolar lavage, nasopharyngeal swab, sputum, and oropharyngeal swab. The CHAINFOR SARS-CoV-2 Detection RT-qPCR Kit is a rapid RT-PCR test that enables reverse transcription and Real-Time PCR. The CHAINFOR SARS-CoV-2 Detection RT-qPCR Kit is optimized with a viral transport medium (VTFOR) or viral nucleic acid transport medium (VNFOR). In an area where the COVID-19 virus is not circulating, a positive RT-qPCR result for at least two distinct targets on the COVID-19 viral genome, at least one of which is preferably specific to the COVID-19 virus, is indicated. Where the COVID-19 virus is widespread, an RT-qPCR result for a single distinct target, such as the N gene, is considered sufficient. The CHAINFOR S SARS-CoV-2 Detection RT-qPCR Kit targets N1 and N2 genes in the SARS-CoV-2 genome based on readout of the FAM channel. The kit also targets the RNase P gene in the human genome as an internal control based on the readout of the HEX channel. In addition, the kits include highly processive Reverse Transcriptase and Hot start Taq polymerase enzymes. The CHAINFOR SARS-CoV-2 Detection RT-qPCR Kit was analyzed for cross-reactivity and interference substances,